Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease

Andres M. Bratt-Leal, Thorsten Gorba, Roy M. Williams, Jim A. Mossman, Rachel Hills, Ha Tran, Derren Barken, Genevieve Beauvais, Daniel Fremgen, Ai Zhang, Cullen Pivaroff, Candace Lynch, Yanzheng Liu, Chandnee Chandrasekaran, David Tastad, Charlotte Bridge, Dustin R. Wakeman, Uyen Nguyen, Brent Chamberlain, Emma L. Lane, Mariah J. Lelos, Jeanne F. Loring, Edward D. Wirth, Xiaokui Zhang

Open source

DOI
10.1016/j.stem.2026.08.014
Published
2026-09
Container
Cell Stem Cell
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.stem.2026.08.014,
  title = {Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease},
  author = {Andres M. Bratt-Leal and Thorsten Gorba and Roy M. Williams and Jim A. Mossman and Rachel Hills and Ha Tran and Derren Barken and Genevieve Beauvais and Daniel Fremgen and Ai Zhang and Cullen Pivaroff and Candace Lynch and Yanzheng Liu and Chandnee Chandrasekaran and David Tastad and Charlotte Bridge and Dustin R. Wakeman and Uyen Nguyen and Brent Chamberlain and Emma L. Lane and Mariah J. Lelos and Jeanne F. Loring and Edward D. Wirth and Xiaokui Zhang},
  year = {2026},
  journal = {Cell Stem Cell},
  doi = {10.1016/j.stem.2026.08.014},
  url = {https://doi.org/10.1016/j.stem.2026.08.014}
}

RIS

TY  - JOUR
TI  - Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease
AU  - Andres M. Bratt-Leal
AU  - Thorsten Gorba
AU  - Roy M. Williams
AU  - Jim A. Mossman
AU  - Rachel Hills
AU  - Ha Tran
AU  - Derren Barken
AU  - Genevieve Beauvais
AU  - Daniel Fremgen
AU  - Ai Zhang
AU  - Cullen Pivaroff
AU  - Candace Lynch
AU  - Yanzheng Liu
AU  - Chandnee Chandrasekaran
AU  - David Tastad
AU  - Charlotte Bridge
AU  - Dustin R. Wakeman
AU  - Uyen Nguyen
AU  - Brent Chamberlain
AU  - Emma L. Lane
AU  - Mariah J. Lelos
AU  - Jeanne F. Loring
AU  - Edward D. Wirth
AU  - Xiaokui Zhang
PY  - 2026
JO  - Cell Stem Cell
DO  - 10.1016/j.stem.2026.08.014
UR  - https://doi.org/10.1016/j.stem.2026.08.014
ER  - 

APA

Bratt-Leal, A. M., Gorba, T., Williams, R. M., Mossman, J. A., Hills, R., Tran, H., Barken, D., Beauvais, G., Fremgen, D., Zhang, A., Pivaroff, C., Lynch, C., Liu, Y., Chandrasekaran, C., Tastad, D., Bridge, C., Wakeman, D. R., Nguyen, U., Chamberlain, B., Lane, E. L., Lelos, M. J., Loring, J. F., Wirth, E. D., & Zhang, X. (2026). Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.08.014

Source records